CIK 0001469443
- Non-accelerated filer
- Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810571538
- Phone
- +1 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- 4 Open-market buy Chief Technology Officer bought 700 shares at $3.16 ($2,212)
- 4 Open-market buy Chief Financial Officer bought 700 shares at $3.16 ($2,212)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 700 shares at $1.72 ($1,204)
- 4 Open-market buy Chief Commercial Officer bought 700 shares at $1.72 ($1,204)
- 4 Open-market buy Chief Executive Officer bought 700 shares at $1.72 ($1,204)
- 4 Open-market buy Chief Commercial Officer bought 900 shares at $5.95 ($5,355)
- 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $4.52 ($4,520)
- 4 Open-market buy Director bought 5,000 shares at $4.25 ($21,250)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.08 ($4,080)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $5.25 ($10,500)
- 4 Open-market buy Director bought 5,000 shares at $5.88 ($29,388)
Page 4 of 11 · 203 filings